BC

Base4 Capital

Description

Base4 Capital is an investment firm.

Investor Profile

Base4 Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Base4 Capital frequently co-invest with?

NFX
North America, California, United States, San Francisco
Co-Investments: 1
LionBird
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Base4 Capital?

Centivax

South San Francisco, California, United States

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics
Series AJul 8, 2025
Amount Raised: $45,000,000
Mana.bio

San Francisco, California, United States

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.

Biotechnology
SeedOct 10, 2023
Amount Raised: $19,500,000